Global Non-oncology Biopharmaceuticals Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Non-oncology Biopharmaceuticals market size was valued at USD 304180 million in 2023 and is forecast to a readjusted size of USD 519380 million by 2030 with a CAGR of 7.9% during review period.
Biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial. This report studies Non-oncology biopharmaceutical which are the drugs that are used in the treatment of various diseases rather than cancer.
The Global Info Research report includes an overview of the development of the Non-oncology Biopharmaceuticals industry chain, the market status of Immunology (Biologics, Biosimilars), Endocrinology (Biologics, Biosimilars), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Non-oncology Biopharmaceuticals.
Regionally, the report analyzes the Non-oncology Biopharmaceuticals markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Non-oncology Biopharmaceuticals market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Non-oncology Biopharmaceuticals market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Non-oncology Biopharmaceuticals industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Biologics, Biosimilars).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Non-oncology Biopharmaceuticals market.
Regional Analysis: The report involves examining the Non-oncology Biopharmaceuticals market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Non-oncology Biopharmaceuticals market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Non-oncology Biopharmaceuticals:
Company Analysis: Report covers individual Non-oncology Biopharmaceuticals players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Non-oncology Biopharmaceuticals This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immunology, Endocrinology).
Technology Analysis: Report covers specific technologies relevant to Non-oncology Biopharmaceuticals. It assesses the current state, advancements, and potential future developments in Non-oncology Biopharmaceuticals areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Non-oncology Biopharmaceuticals market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Non-oncology Biopharmaceuticals market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Non-oncology Biopharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-oncology Biopharmaceuticals, with revenue, gross margin and global market share of Non-oncology Biopharmaceuticals from 2019 to 2024.
Chapter 3, the Non-oncology Biopharmaceuticals competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Non-oncology Biopharmaceuticals market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-oncology Biopharmaceuticals.
Chapter 13, to describe Non-oncology Biopharmaceuticals research findings and conclusion.
Biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial. This report studies Non-oncology biopharmaceutical which are the drugs that are used in the treatment of various diseases rather than cancer.
The Global Info Research report includes an overview of the development of the Non-oncology Biopharmaceuticals industry chain, the market status of Immunology (Biologics, Biosimilars), Endocrinology (Biologics, Biosimilars), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Non-oncology Biopharmaceuticals.
Regionally, the report analyzes the Non-oncology Biopharmaceuticals markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Non-oncology Biopharmaceuticals market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Non-oncology Biopharmaceuticals market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Non-oncology Biopharmaceuticals industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Biologics, Biosimilars).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Non-oncology Biopharmaceuticals market.
Regional Analysis: The report involves examining the Non-oncology Biopharmaceuticals market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Non-oncology Biopharmaceuticals market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Non-oncology Biopharmaceuticals:
Company Analysis: Report covers individual Non-oncology Biopharmaceuticals players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Non-oncology Biopharmaceuticals This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immunology, Endocrinology).
Technology Analysis: Report covers specific technologies relevant to Non-oncology Biopharmaceuticals. It assesses the current state, advancements, and potential future developments in Non-oncology Biopharmaceuticals areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Non-oncology Biopharmaceuticals market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Non-oncology Biopharmaceuticals market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Biologics
- Biosimilars
- Immunology
- Endocrinology
- Others
- Roche
- Sanofi
- Johnson & Johnson
- Pfizer
- Novo Nordisk
- Novartis
- Merck
- Teva
- Eli Lilly
- Bristol-Myers Squibb
- GlaxoSmithKline
- UCB Pharma
- Amgen
- AbbVie
- Takeda
- AstraZeneca
- Mylan
- LEO Pharma
- Boehringer Ingelheim
- Alexion Pharmaceuticals
- Elusys Therapeutics
- Swedish Orphan Biovitrum
- Biogen
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Non-oncology Biopharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-oncology Biopharmaceuticals, with revenue, gross margin and global market share of Non-oncology Biopharmaceuticals from 2019 to 2024.
Chapter 3, the Non-oncology Biopharmaceuticals competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Non-oncology Biopharmaceuticals market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-oncology Biopharmaceuticals.
Chapter 13, to describe Non-oncology Biopharmaceuticals research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Non-oncology Biopharmaceuticals
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-oncology Biopharmaceuticals by Type
1.3.1 Overview: Global Non-oncology Biopharmaceuticals Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Non-oncology Biopharmaceuticals Consumption Value Market Share by Type in 2023
1.3.3 Biologics
1.3.4 Biosimilars
1.4 Global Non-oncology Biopharmaceuticals Market by Application
1.4.1 Overview: Global Non-oncology Biopharmaceuticals Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Immunology
1.4.3 Endocrinology
1.4.4 Others
1.5 Global Non-oncology Biopharmaceuticals Market Size & Forecast
1.6 Global Non-oncology Biopharmaceuticals Market Size and Forecast by Region
1.6.1 Global Non-oncology Biopharmaceuticals Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Non-oncology Biopharmaceuticals Market Size by Region, (2019-2030)
1.6.3 North America Non-oncology Biopharmaceuticals Market Size and Prospect (2019-2030)
1.6.4 Europe Non-oncology Biopharmaceuticals Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Non-oncology Biopharmaceuticals Market Size and Prospect (2019-2030)
1.6.6 South America Non-oncology Biopharmaceuticals Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Non-oncology Biopharmaceuticals Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Non-oncology Biopharmaceuticals Product and Solutions
2.1.4 Roche Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Non-oncology Biopharmaceuticals Product and Solutions
2.2.4 Sanofi Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Non-oncology Biopharmaceuticals Product and Solutions
2.3.4 Johnson & Johnson Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Johnson & Johnson Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Non-oncology Biopharmaceuticals Product and Solutions
2.4.4 Pfizer Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 Novo Nordisk
2.5.1 Novo Nordisk Details
2.5.2 Novo Nordisk Major Business
2.5.3 Novo Nordisk Non-oncology Biopharmaceuticals Product and Solutions
2.5.4 Novo Nordisk Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Novo Nordisk Recent Developments and Future Plans
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Non-oncology Biopharmaceuticals Product and Solutions
2.6.4 Novartis Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Novartis Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Non-oncology Biopharmaceuticals Product and Solutions
2.7.4 Merck Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Merck Recent Developments and Future Plans
2.8 Teva
2.8.1 Teva Details
2.8.2 Teva Major Business
2.8.3 Teva Non-oncology Biopharmaceuticals Product and Solutions
2.8.4 Teva Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Teva Recent Developments and Future Plans
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Non-oncology Biopharmaceuticals Product and Solutions
2.9.4 Eli Lilly Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Eli Lilly Recent Developments and Future Plans
2.10 Bristol-Myers Squibb
2.10.1 Bristol-Myers Squibb Details
2.10.2 Bristol-Myers Squibb Major Business
2.10.3 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product and Solutions
2.10.4 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.11 GlaxoSmithKline
2.11.1 GlaxoSmithKline Details
2.11.2 GlaxoSmithKline Major Business
2.11.3 GlaxoSmithKline Non-oncology Biopharmaceuticals Product and Solutions
2.11.4 GlaxoSmithKline Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 GlaxoSmithKline Recent Developments and Future Plans
2.12 UCB Pharma
2.12.1 UCB Pharma Details
2.12.2 UCB Pharma Major Business
2.12.3 UCB Pharma Non-oncology Biopharmaceuticals Product and Solutions
2.12.4 UCB Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 UCB Pharma Recent Developments and Future Plans
2.13 Amgen
2.13.1 Amgen Details
2.13.2 Amgen Major Business
2.13.3 Amgen Non-oncology Biopharmaceuticals Product and Solutions
2.13.4 Amgen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Amgen Recent Developments and Future Plans
2.14 AbbVie
2.14.1 AbbVie Details
2.14.2 AbbVie Major Business
2.14.3 AbbVie Non-oncology Biopharmaceuticals Product and Solutions
2.14.4 AbbVie Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 AbbVie Recent Developments and Future Plans
2.15 Takeda
2.15.1 Takeda Details
2.15.2 Takeda Major Business
2.15.3 Takeda Non-oncology Biopharmaceuticals Product and Solutions
2.15.4 Takeda Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Takeda Recent Developments and Future Plans
2.16 AstraZeneca
2.16.1 AstraZeneca Details
2.16.2 AstraZeneca Major Business
2.16.3 AstraZeneca Non-oncology Biopharmaceuticals Product and Solutions
2.16.4 AstraZeneca Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 AstraZeneca Recent Developments and Future Plans
2.17 Mylan
2.17.1 Mylan Details
2.17.2 Mylan Major Business
2.17.3 Mylan Non-oncology Biopharmaceuticals Product and Solutions
2.17.4 Mylan Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Mylan Recent Developments and Future Plans
2.18 LEO Pharma
2.18.1 LEO Pharma Details
2.18.2 LEO Pharma Major Business
2.18.3 LEO Pharma Non-oncology Biopharmaceuticals Product and Solutions
2.18.4 LEO Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 LEO Pharma Recent Developments and Future Plans
2.19 Boehringer Ingelheim
2.19.1 Boehringer Ingelheim Details
2.19.2 Boehringer Ingelheim Major Business
2.19.3 Boehringer Ingelheim Non-oncology Biopharmaceuticals Product and Solutions
2.19.4 Boehringer Ingelheim Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Boehringer Ingelheim Recent Developments and Future Plans
2.20 Alexion Pharmaceuticals
2.20.1 Alexion Pharmaceuticals Details
2.20.2 Alexion Pharmaceuticals Major Business
2.20.3 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product and Solutions
2.20.4 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Alexion Pharmaceuticals Recent Developments and Future Plans
2.21 Elusys Therapeutics
2.21.1 Elusys Therapeutics Details
2.21.2 Elusys Therapeutics Major Business
2.21.3 Elusys Therapeutics Non-oncology Biopharmaceuticals Product and Solutions
2.21.4 Elusys Therapeutics Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Elusys Therapeutics Recent Developments and Future Plans
2.22 Swedish Orphan Biovitrum
2.22.1 Swedish Orphan Biovitrum Details
2.22.2 Swedish Orphan Biovitrum Major Business
2.22.3 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product and Solutions
2.22.4 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Swedish Orphan Biovitrum Recent Developments and Future Plans
2.23 Biogen
2.23.1 Biogen Details
2.23.2 Biogen Major Business
2.23.3 Biogen Non-oncology Biopharmaceuticals Product and Solutions
2.23.4 Biogen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.23.5 Biogen Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Non-oncology Biopharmaceuticals Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Non-oncology Biopharmaceuticals by Company Revenue
3.2.2 Top 3 Non-oncology Biopharmaceuticals Players Market Share in 2023
3.2.3 Top 6 Non-oncology Biopharmaceuticals Players Market Share in 2023
3.3 Non-oncology Biopharmaceuticals Market: Overall Company Footprint Analysis
3.3.1 Non-oncology Biopharmaceuticals Market: Region Footprint
3.3.2 Non-oncology Biopharmaceuticals Market: Company Product Type Footprint
3.3.3 Non-oncology Biopharmaceuticals Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Non-oncology Biopharmaceuticals Consumption Value and Market Share by Type (2019-2024)
4.2 Global Non-oncology Biopharmaceuticals Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Non-oncology Biopharmaceuticals Consumption Value Market Share by Application (2019-2024)
5.2 Global Non-oncology Biopharmaceuticals Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Non-oncology Biopharmaceuticals Consumption Value by Type (2019-2030)
6.2 North America Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2030)
6.3 North America Non-oncology Biopharmaceuticals Market Size by Country
6.3.1 North America Non-oncology Biopharmaceuticals Consumption Value by Country (2019-2030)
6.3.2 United States Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
6.3.3 Canada Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
6.3.4 Mexico Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Non-oncology Biopharmaceuticals Consumption Value by Type (2019-2030)
7.2 Europe Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2030)
7.3 Europe Non-oncology Biopharmaceuticals Market Size by Country
7.3.1 Europe Non-oncology Biopharmaceuticals Consumption Value by Country (2019-2030)
7.3.2 Germany Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
7.3.3 France Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
7.3.5 Russia Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
7.3.6 Italy Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Non-oncology Biopharmaceuticals Market Size by Region
8.3.1 Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value by Region (2019-2030)
8.3.2 China Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
8.3.3 Japan Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
8.3.4 South Korea Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
8.3.5 India Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
8.3.7 Australia Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Non-oncology Biopharmaceuticals Consumption Value by Type (2019-2030)
9.2 South America Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2030)
9.3 South America Non-oncology Biopharmaceuticals Market Size by Country
9.3.1 South America Non-oncology Biopharmaceuticals Consumption Value by Country (2019-2030)
9.3.2 Brazil Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
9.3.3 Argentina Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non-oncology Biopharmaceuticals Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Country
10.3.1 Middle East & Africa Non-oncology Biopharmaceuticals Consumption Value by Country (2019-2030)
10.3.2 Turkey Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
10.3.4 UAE Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Non-oncology Biopharmaceuticals Market Drivers
11.2 Non-oncology Biopharmaceuticals Market Restraints
11.3 Non-oncology Biopharmaceuticals Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Non-oncology Biopharmaceuticals Industry Chain
12.2 Non-oncology Biopharmaceuticals Upstream Analysis
12.3 Non-oncology Biopharmaceuticals Midstream Analysis
12.4 Non-oncology Biopharmaceuticals Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Non-oncology Biopharmaceuticals
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-oncology Biopharmaceuticals by Type
1.3.1 Overview: Global Non-oncology Biopharmaceuticals Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Non-oncology Biopharmaceuticals Consumption Value Market Share by Type in 2023
1.3.3 Biologics
1.3.4 Biosimilars
1.4 Global Non-oncology Biopharmaceuticals Market by Application
1.4.1 Overview: Global Non-oncology Biopharmaceuticals Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Immunology
1.4.3 Endocrinology
1.4.4 Others
1.5 Global Non-oncology Biopharmaceuticals Market Size & Forecast
1.6 Global Non-oncology Biopharmaceuticals Market Size and Forecast by Region
1.6.1 Global Non-oncology Biopharmaceuticals Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Non-oncology Biopharmaceuticals Market Size by Region, (2019-2030)
1.6.3 North America Non-oncology Biopharmaceuticals Market Size and Prospect (2019-2030)
1.6.4 Europe Non-oncology Biopharmaceuticals Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Non-oncology Biopharmaceuticals Market Size and Prospect (2019-2030)
1.6.6 South America Non-oncology Biopharmaceuticals Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Non-oncology Biopharmaceuticals Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Non-oncology Biopharmaceuticals Product and Solutions
2.1.4 Roche Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Non-oncology Biopharmaceuticals Product and Solutions
2.2.4 Sanofi Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Non-oncology Biopharmaceuticals Product and Solutions
2.3.4 Johnson & Johnson Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Johnson & Johnson Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Non-oncology Biopharmaceuticals Product and Solutions
2.4.4 Pfizer Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 Novo Nordisk
2.5.1 Novo Nordisk Details
2.5.2 Novo Nordisk Major Business
2.5.3 Novo Nordisk Non-oncology Biopharmaceuticals Product and Solutions
2.5.4 Novo Nordisk Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Novo Nordisk Recent Developments and Future Plans
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Non-oncology Biopharmaceuticals Product and Solutions
2.6.4 Novartis Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Novartis Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Non-oncology Biopharmaceuticals Product and Solutions
2.7.4 Merck Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Merck Recent Developments and Future Plans
2.8 Teva
2.8.1 Teva Details
2.8.2 Teva Major Business
2.8.3 Teva Non-oncology Biopharmaceuticals Product and Solutions
2.8.4 Teva Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Teva Recent Developments and Future Plans
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Non-oncology Biopharmaceuticals Product and Solutions
2.9.4 Eli Lilly Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Eli Lilly Recent Developments and Future Plans
2.10 Bristol-Myers Squibb
2.10.1 Bristol-Myers Squibb Details
2.10.2 Bristol-Myers Squibb Major Business
2.10.3 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product and Solutions
2.10.4 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.11 GlaxoSmithKline
2.11.1 GlaxoSmithKline Details
2.11.2 GlaxoSmithKline Major Business
2.11.3 GlaxoSmithKline Non-oncology Biopharmaceuticals Product and Solutions
2.11.4 GlaxoSmithKline Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 GlaxoSmithKline Recent Developments and Future Plans
2.12 UCB Pharma
2.12.1 UCB Pharma Details
2.12.2 UCB Pharma Major Business
2.12.3 UCB Pharma Non-oncology Biopharmaceuticals Product and Solutions
2.12.4 UCB Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 UCB Pharma Recent Developments and Future Plans
2.13 Amgen
2.13.1 Amgen Details
2.13.2 Amgen Major Business
2.13.3 Amgen Non-oncology Biopharmaceuticals Product and Solutions
2.13.4 Amgen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Amgen Recent Developments and Future Plans
2.14 AbbVie
2.14.1 AbbVie Details
2.14.2 AbbVie Major Business
2.14.3 AbbVie Non-oncology Biopharmaceuticals Product and Solutions
2.14.4 AbbVie Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 AbbVie Recent Developments and Future Plans
2.15 Takeda
2.15.1 Takeda Details
2.15.2 Takeda Major Business
2.15.3 Takeda Non-oncology Biopharmaceuticals Product and Solutions
2.15.4 Takeda Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Takeda Recent Developments and Future Plans
2.16 AstraZeneca
2.16.1 AstraZeneca Details
2.16.2 AstraZeneca Major Business
2.16.3 AstraZeneca Non-oncology Biopharmaceuticals Product and Solutions
2.16.4 AstraZeneca Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 AstraZeneca Recent Developments and Future Plans
2.17 Mylan
2.17.1 Mylan Details
2.17.2 Mylan Major Business
2.17.3 Mylan Non-oncology Biopharmaceuticals Product and Solutions
2.17.4 Mylan Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Mylan Recent Developments and Future Plans
2.18 LEO Pharma
2.18.1 LEO Pharma Details
2.18.2 LEO Pharma Major Business
2.18.3 LEO Pharma Non-oncology Biopharmaceuticals Product and Solutions
2.18.4 LEO Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 LEO Pharma Recent Developments and Future Plans
2.19 Boehringer Ingelheim
2.19.1 Boehringer Ingelheim Details
2.19.2 Boehringer Ingelheim Major Business
2.19.3 Boehringer Ingelheim Non-oncology Biopharmaceuticals Product and Solutions
2.19.4 Boehringer Ingelheim Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Boehringer Ingelheim Recent Developments and Future Plans
2.20 Alexion Pharmaceuticals
2.20.1 Alexion Pharmaceuticals Details
2.20.2 Alexion Pharmaceuticals Major Business
2.20.3 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product and Solutions
2.20.4 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Alexion Pharmaceuticals Recent Developments and Future Plans
2.21 Elusys Therapeutics
2.21.1 Elusys Therapeutics Details
2.21.2 Elusys Therapeutics Major Business
2.21.3 Elusys Therapeutics Non-oncology Biopharmaceuticals Product and Solutions
2.21.4 Elusys Therapeutics Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Elusys Therapeutics Recent Developments and Future Plans
2.22 Swedish Orphan Biovitrum
2.22.1 Swedish Orphan Biovitrum Details
2.22.2 Swedish Orphan Biovitrum Major Business
2.22.3 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product and Solutions
2.22.4 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Swedish Orphan Biovitrum Recent Developments and Future Plans
2.23 Biogen
2.23.1 Biogen Details
2.23.2 Biogen Major Business
2.23.3 Biogen Non-oncology Biopharmaceuticals Product and Solutions
2.23.4 Biogen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2024)
2.23.5 Biogen Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Non-oncology Biopharmaceuticals Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Non-oncology Biopharmaceuticals by Company Revenue
3.2.2 Top 3 Non-oncology Biopharmaceuticals Players Market Share in 2023
3.2.3 Top 6 Non-oncology Biopharmaceuticals Players Market Share in 2023
3.3 Non-oncology Biopharmaceuticals Market: Overall Company Footprint Analysis
3.3.1 Non-oncology Biopharmaceuticals Market: Region Footprint
3.3.2 Non-oncology Biopharmaceuticals Market: Company Product Type Footprint
3.3.3 Non-oncology Biopharmaceuticals Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Non-oncology Biopharmaceuticals Consumption Value and Market Share by Type (2019-2024)
4.2 Global Non-oncology Biopharmaceuticals Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Non-oncology Biopharmaceuticals Consumption Value Market Share by Application (2019-2024)
5.2 Global Non-oncology Biopharmaceuticals Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Non-oncology Biopharmaceuticals Consumption Value by Type (2019-2030)
6.2 North America Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2030)
6.3 North America Non-oncology Biopharmaceuticals Market Size by Country
6.3.1 North America Non-oncology Biopharmaceuticals Consumption Value by Country (2019-2030)
6.3.2 United States Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
6.3.3 Canada Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
6.3.4 Mexico Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Non-oncology Biopharmaceuticals Consumption Value by Type (2019-2030)
7.2 Europe Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2030)
7.3 Europe Non-oncology Biopharmaceuticals Market Size by Country
7.3.1 Europe Non-oncology Biopharmaceuticals Consumption Value by Country (2019-2030)
7.3.2 Germany Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
7.3.3 France Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
7.3.5 Russia Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
7.3.6 Italy Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Non-oncology Biopharmaceuticals Market Size by Region
8.3.1 Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value by Region (2019-2030)
8.3.2 China Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
8.3.3 Japan Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
8.3.4 South Korea Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
8.3.5 India Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
8.3.7 Australia Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Non-oncology Biopharmaceuticals Consumption Value by Type (2019-2030)
9.2 South America Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2030)
9.3 South America Non-oncology Biopharmaceuticals Market Size by Country
9.3.1 South America Non-oncology Biopharmaceuticals Consumption Value by Country (2019-2030)
9.3.2 Brazil Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
9.3.3 Argentina Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non-oncology Biopharmaceuticals Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Country
10.3.1 Middle East & Africa Non-oncology Biopharmaceuticals Consumption Value by Country (2019-2030)
10.3.2 Turkey Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
10.3.4 UAE Non-oncology Biopharmaceuticals Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Non-oncology Biopharmaceuticals Market Drivers
11.2 Non-oncology Biopharmaceuticals Market Restraints
11.3 Non-oncology Biopharmaceuticals Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Non-oncology Biopharmaceuticals Industry Chain
12.2 Non-oncology Biopharmaceuticals Upstream Analysis
12.3 Non-oncology Biopharmaceuticals Midstream Analysis
12.4 Non-oncology Biopharmaceuticals Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Non-oncology Biopharmaceuticals Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Non-oncology Biopharmaceuticals Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Non-oncology Biopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Non-oncology Biopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Non-oncology Biopharmaceuticals Product and Solutions
Table 8. Roche Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Roche Recent Developments and Future Plans
Table 10. Sanofi Company Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Non-oncology Biopharmaceuticals Product and Solutions
Table 13. Sanofi Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Sanofi Recent Developments and Future Plans
Table 15. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Non-oncology Biopharmaceuticals Product and Solutions
Table 18. Johnson & Johnson Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Johnson & Johnson Recent Developments and Future Plans
Table 20. Pfizer Company Information, Head Office, and Major Competitors
Table 21. Pfizer Major Business
Table 22. Pfizer Non-oncology Biopharmaceuticals Product and Solutions
Table 23. Pfizer Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Pfizer Recent Developments and Future Plans
Table 25. Novo Nordisk Company Information, Head Office, and Major Competitors
Table 26. Novo Nordisk Major Business
Table 27. Novo Nordisk Non-oncology Biopharmaceuticals Product and Solutions
Table 28. Novo Nordisk Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Novo Nordisk Recent Developments and Future Plans
Table 30. Novartis Company Information, Head Office, and Major Competitors
Table 31. Novartis Major Business
Table 32. Novartis Non-oncology Biopharmaceuticals Product and Solutions
Table 33. Novartis Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Novartis Recent Developments and Future Plans
Table 35. Merck Company Information, Head Office, and Major Competitors
Table 36. Merck Major Business
Table 37. Merck Non-oncology Biopharmaceuticals Product and Solutions
Table 38. Merck Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Merck Recent Developments and Future Plans
Table 40. Teva Company Information, Head Office, and Major Competitors
Table 41. Teva Major Business
Table 42. Teva Non-oncology Biopharmaceuticals Product and Solutions
Table 43. Teva Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Teva Recent Developments and Future Plans
Table 45. Eli Lilly Company Information, Head Office, and Major Competitors
Table 46. Eli Lilly Major Business
Table 47. Eli Lilly Non-oncology Biopharmaceuticals Product and Solutions
Table 48. Eli Lilly Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Eli Lilly Recent Developments and Future Plans
Table 50. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 51. Bristol-Myers Squibb Major Business
Table 52. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product and Solutions
Table 53. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Bristol-Myers Squibb Recent Developments and Future Plans
Table 55. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 56. GlaxoSmithKline Major Business
Table 57. GlaxoSmithKline Non-oncology Biopharmaceuticals Product and Solutions
Table 58. GlaxoSmithKline Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. GlaxoSmithKline Recent Developments and Future Plans
Table 60. UCB Pharma Company Information, Head Office, and Major Competitors
Table 61. UCB Pharma Major Business
Table 62. UCB Pharma Non-oncology Biopharmaceuticals Product and Solutions
Table 63. UCB Pharma Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. UCB Pharma Recent Developments and Future Plans
Table 65. Amgen Company Information, Head Office, and Major Competitors
Table 66. Amgen Major Business
Table 67. Amgen Non-oncology Biopharmaceuticals Product and Solutions
Table 68. Amgen Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Amgen Recent Developments and Future Plans
Table 70. AbbVie Company Information, Head Office, and Major Competitors
Table 71. AbbVie Major Business
Table 72. AbbVie Non-oncology Biopharmaceuticals Product and Solutions
Table 73. AbbVie Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. AbbVie Recent Developments and Future Plans
Table 75. Takeda Company Information, Head Office, and Major Competitors
Table 76. Takeda Major Business
Table 77. Takeda Non-oncology Biopharmaceuticals Product and Solutions
Table 78. Takeda Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Takeda Recent Developments and Future Plans
Table 80. AstraZeneca Company Information, Head Office, and Major Competitors
Table 81. AstraZeneca Major Business
Table 82. AstraZeneca Non-oncology Biopharmaceuticals Product and Solutions
Table 83. AstraZeneca Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. AstraZeneca Recent Developments and Future Plans
Table 85. Mylan Company Information, Head Office, and Major Competitors
Table 86. Mylan Major Business
Table 87. Mylan Non-oncology Biopharmaceuticals Product and Solutions
Table 88. Mylan Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Mylan Recent Developments and Future Plans
Table 90. LEO Pharma Company Information, Head Office, and Major Competitors
Table 91. LEO Pharma Major Business
Table 92. LEO Pharma Non-oncology Biopharmaceuticals Product and Solutions
Table 93. LEO Pharma Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. LEO Pharma Recent Developments and Future Plans
Table 95. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 96. Boehringer Ingelheim Major Business
Table 97. Boehringer Ingelheim Non-oncology Biopharmaceuticals Product and Solutions
Table 98. Boehringer Ingelheim Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Boehringer Ingelheim Recent Developments and Future Plans
Table 100. Alexion Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 101. Alexion Pharmaceuticals Major Business
Table 102. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product and Solutions
Table 103. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Alexion Pharmaceuticals Recent Developments and Future Plans
Table 105. Elusys Therapeutics Company Information, Head Office, and Major Competitors
Table 106. Elusys Therapeutics Major Business
Table 107. Elusys Therapeutics Non-oncology Biopharmaceuticals Product and Solutions
Table 108. Elusys Therapeutics Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. Elusys Therapeutics Recent Developments and Future Plans
Table 110. Swedish Orphan Biovitrum Company Information, Head Office, and Major Competitors
Table 111. Swedish Orphan Biovitrum Major Business
Table 112. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product and Solutions
Table 113. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 114. Swedish Orphan Biovitrum Recent Developments and Future Plans
Table 115. Biogen Company Information, Head Office, and Major Competitors
Table 116. Biogen Major Business
Table 117. Biogen Non-oncology Biopharmaceuticals Product and Solutions
Table 118. Biogen Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Biogen Recent Developments and Future Plans
Table 120. Global Non-oncology Biopharmaceuticals Revenue (USD Million) by Players (2019-2024)
Table 121. Global Non-oncology Biopharmaceuticals Revenue Share by Players (2019-2024)
Table 122. Breakdown of Non-oncology Biopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3)
Table 123. Market Position of Players in Non-oncology Biopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 124. Head Office of Key Non-oncology Biopharmaceuticals Players
Table 125. Non-oncology Biopharmaceuticals Market: Company Product Type Footprint
Table 126. Non-oncology Biopharmaceuticals Market: Company Product Application Footprint
Table 127. Non-oncology Biopharmaceuticals New Market Entrants and Barriers to Market Entry
Table 128. Non-oncology Biopharmaceuticals Mergers, Acquisition, Agreements, and Collaborations
Table 129. Global Non-oncology Biopharmaceuticals Consumption Value (USD Million) by Type (2019-2024)
Table 130. Global Non-oncology Biopharmaceuticals Consumption Value Share by Type (2019-2024)
Table 131. Global Non-oncology Biopharmaceuticals Consumption Value Forecast by Type (2025-2030)
Table 132. Global Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2024)
Table 133. Global Non-oncology Biopharmaceuticals Consumption Value Forecast by Application (2025-2030)
Table 134. North America Non-oncology Biopharmaceuticals Consumption Value by Type (2019-2024) & (USD Million)
Table 135. North America Non-oncology Biopharmaceuticals Consumption Value by Type (2025-2030) & (USD Million)
Table 136. North America Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2024) & (USD Million)
Table 137. North America Non-oncology Biopharmaceuticals Consumption Value by Application (2025-2030) & (USD Million)
Table 138. North America Non-oncology Biopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 139. North America Non-oncology Biopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 140. Europe Non-oncology Biopharmaceuticals Consumption Value by Type (2019-2024) & (USD Million)
Table 141. Europe Non-oncology Biopharmaceuticals Consumption Value by Type (2025-2030) & (USD Million)
Table 142. Europe Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2024) & (USD Million)
Table 143. Europe Non-oncology Biopharmaceuticals Consumption Value by Application (2025-2030) & (USD Million)
Table 144. Europe Non-oncology Biopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 145. Europe Non-oncology Biopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 146. Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value by Type (2019-2024) & (USD Million)
Table 147. Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value by Type (2025-2030) & (USD Million)
Table 148. Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2024) & (USD Million)
Table 149. Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value by Application (2025-2030) & (USD Million)
Table 150. Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 151. Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 152. South America Non-oncology Biopharmaceuticals Consumption Value by Type (2019-2024) & (USD Million)
Table 153. South America Non-oncology Biopharmaceuticals Consumption Value by Type (2025-2030) & (USD Million)
Table 154. South America Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2024) & (USD Million)
Table 155. South America Non-oncology Biopharmaceuticals Consumption Value by Application (2025-2030) & (USD Million)
Table 156. South America Non-oncology Biopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 157. South America Non-oncology Biopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 158. Middle East & Africa Non-oncology Biopharmaceuticals Consumption Value by Type (2019-2024) & (USD Million)
Table 159. Middle East & Africa Non-oncology Biopharmaceuticals Consumption Value by Type (2025-2030) & (USD Million)
Table 160. Middle East & Africa Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2024) & (USD Million)
Table 161. Middle East & Africa Non-oncology Biopharmaceuticals Consumption Value by Application (2025-2030) & (USD Million)
Table 162. Middle East & Africa Non-oncology Biopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 163. Middle East & Africa Non-oncology Biopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 164. Non-oncology Biopharmaceuticals Raw Material
Table 165. Key Suppliers of Non-oncology Biopharmaceuticals Raw Materials
Table 1. Global Non-oncology Biopharmaceuticals Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Non-oncology Biopharmaceuticals Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Non-oncology Biopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Non-oncology Biopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Non-oncology Biopharmaceuticals Product and Solutions
Table 8. Roche Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Roche Recent Developments and Future Plans
Table 10. Sanofi Company Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Non-oncology Biopharmaceuticals Product and Solutions
Table 13. Sanofi Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Sanofi Recent Developments and Future Plans
Table 15. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Non-oncology Biopharmaceuticals Product and Solutions
Table 18. Johnson & Johnson Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Johnson & Johnson Recent Developments and Future Plans
Table 20. Pfizer Company Information, Head Office, and Major Competitors
Table 21. Pfizer Major Business
Table 22. Pfizer Non-oncology Biopharmaceuticals Product and Solutions
Table 23. Pfizer Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Pfizer Recent Developments and Future Plans
Table 25. Novo Nordisk Company Information, Head Office, and Major Competitors
Table 26. Novo Nordisk Major Business
Table 27. Novo Nordisk Non-oncology Biopharmaceuticals Product and Solutions
Table 28. Novo Nordisk Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Novo Nordisk Recent Developments and Future Plans
Table 30. Novartis Company Information, Head Office, and Major Competitors
Table 31. Novartis Major Business
Table 32. Novartis Non-oncology Biopharmaceuticals Product and Solutions
Table 33. Novartis Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Novartis Recent Developments and Future Plans
Table 35. Merck Company Information, Head Office, and Major Competitors
Table 36. Merck Major Business
Table 37. Merck Non-oncology Biopharmaceuticals Product and Solutions
Table 38. Merck Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Merck Recent Developments and Future Plans
Table 40. Teva Company Information, Head Office, and Major Competitors
Table 41. Teva Major Business
Table 42. Teva Non-oncology Biopharmaceuticals Product and Solutions
Table 43. Teva Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Teva Recent Developments and Future Plans
Table 45. Eli Lilly Company Information, Head Office, and Major Competitors
Table 46. Eli Lilly Major Business
Table 47. Eli Lilly Non-oncology Biopharmaceuticals Product and Solutions
Table 48. Eli Lilly Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Eli Lilly Recent Developments and Future Plans
Table 50. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 51. Bristol-Myers Squibb Major Business
Table 52. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product and Solutions
Table 53. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Bristol-Myers Squibb Recent Developments and Future Plans
Table 55. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 56. GlaxoSmithKline Major Business
Table 57. GlaxoSmithKline Non-oncology Biopharmaceuticals Product and Solutions
Table 58. GlaxoSmithKline Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. GlaxoSmithKline Recent Developments and Future Plans
Table 60. UCB Pharma Company Information, Head Office, and Major Competitors
Table 61. UCB Pharma Major Business
Table 62. UCB Pharma Non-oncology Biopharmaceuticals Product and Solutions
Table 63. UCB Pharma Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. UCB Pharma Recent Developments and Future Plans
Table 65. Amgen Company Information, Head Office, and Major Competitors
Table 66. Amgen Major Business
Table 67. Amgen Non-oncology Biopharmaceuticals Product and Solutions
Table 68. Amgen Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Amgen Recent Developments and Future Plans
Table 70. AbbVie Company Information, Head Office, and Major Competitors
Table 71. AbbVie Major Business
Table 72. AbbVie Non-oncology Biopharmaceuticals Product and Solutions
Table 73. AbbVie Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. AbbVie Recent Developments and Future Plans
Table 75. Takeda Company Information, Head Office, and Major Competitors
Table 76. Takeda Major Business
Table 77. Takeda Non-oncology Biopharmaceuticals Product and Solutions
Table 78. Takeda Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Takeda Recent Developments and Future Plans
Table 80. AstraZeneca Company Information, Head Office, and Major Competitors
Table 81. AstraZeneca Major Business
Table 82. AstraZeneca Non-oncology Biopharmaceuticals Product and Solutions
Table 83. AstraZeneca Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. AstraZeneca Recent Developments and Future Plans
Table 85. Mylan Company Information, Head Office, and Major Competitors
Table 86. Mylan Major Business
Table 87. Mylan Non-oncology Biopharmaceuticals Product and Solutions
Table 88. Mylan Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Mylan Recent Developments and Future Plans
Table 90. LEO Pharma Company Information, Head Office, and Major Competitors
Table 91. LEO Pharma Major Business
Table 92. LEO Pharma Non-oncology Biopharmaceuticals Product and Solutions
Table 93. LEO Pharma Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. LEO Pharma Recent Developments and Future Plans
Table 95. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 96. Boehringer Ingelheim Major Business
Table 97. Boehringer Ingelheim Non-oncology Biopharmaceuticals Product and Solutions
Table 98. Boehringer Ingelheim Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Boehringer Ingelheim Recent Developments and Future Plans
Table 100. Alexion Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 101. Alexion Pharmaceuticals Major Business
Table 102. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product and Solutions
Table 103. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Alexion Pharmaceuticals Recent Developments and Future Plans
Table 105. Elusys Therapeutics Company Information, Head Office, and Major Competitors
Table 106. Elusys Therapeutics Major Business
Table 107. Elusys Therapeutics Non-oncology Biopharmaceuticals Product and Solutions
Table 108. Elusys Therapeutics Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. Elusys Therapeutics Recent Developments and Future Plans
Table 110. Swedish Orphan Biovitrum Company Information, Head Office, and Major Competitors
Table 111. Swedish Orphan Biovitrum Major Business
Table 112. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product and Solutions
Table 113. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 114. Swedish Orphan Biovitrum Recent Developments and Future Plans
Table 115. Biogen Company Information, Head Office, and Major Competitors
Table 116. Biogen Major Business
Table 117. Biogen Non-oncology Biopharmaceuticals Product and Solutions
Table 118. Biogen Non-oncology Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Biogen Recent Developments and Future Plans
Table 120. Global Non-oncology Biopharmaceuticals Revenue (USD Million) by Players (2019-2024)
Table 121. Global Non-oncology Biopharmaceuticals Revenue Share by Players (2019-2024)
Table 122. Breakdown of Non-oncology Biopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3)
Table 123. Market Position of Players in Non-oncology Biopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 124. Head Office of Key Non-oncology Biopharmaceuticals Players
Table 125. Non-oncology Biopharmaceuticals Market: Company Product Type Footprint
Table 126. Non-oncology Biopharmaceuticals Market: Company Product Application Footprint
Table 127. Non-oncology Biopharmaceuticals New Market Entrants and Barriers to Market Entry
Table 128. Non-oncology Biopharmaceuticals Mergers, Acquisition, Agreements, and Collaborations
Table 129. Global Non-oncology Biopharmaceuticals Consumption Value (USD Million) by Type (2019-2024)
Table 130. Global Non-oncology Biopharmaceuticals Consumption Value Share by Type (2019-2024)
Table 131. Global Non-oncology Biopharmaceuticals Consumption Value Forecast by Type (2025-2030)
Table 132. Global Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2024)
Table 133. Global Non-oncology Biopharmaceuticals Consumption Value Forecast by Application (2025-2030)
Table 134. North America Non-oncology Biopharmaceuticals Consumption Value by Type (2019-2024) & (USD Million)
Table 135. North America Non-oncology Biopharmaceuticals Consumption Value by Type (2025-2030) & (USD Million)
Table 136. North America Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2024) & (USD Million)
Table 137. North America Non-oncology Biopharmaceuticals Consumption Value by Application (2025-2030) & (USD Million)
Table 138. North America Non-oncology Biopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 139. North America Non-oncology Biopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 140. Europe Non-oncology Biopharmaceuticals Consumption Value by Type (2019-2024) & (USD Million)
Table 141. Europe Non-oncology Biopharmaceuticals Consumption Value by Type (2025-2030) & (USD Million)
Table 142. Europe Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2024) & (USD Million)
Table 143. Europe Non-oncology Biopharmaceuticals Consumption Value by Application (2025-2030) & (USD Million)
Table 144. Europe Non-oncology Biopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 145. Europe Non-oncology Biopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 146. Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value by Type (2019-2024) & (USD Million)
Table 147. Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value by Type (2025-2030) & (USD Million)
Table 148. Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2024) & (USD Million)
Table 149. Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value by Application (2025-2030) & (USD Million)
Table 150. Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 151. Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 152. South America Non-oncology Biopharmaceuticals Consumption Value by Type (2019-2024) & (USD Million)
Table 153. South America Non-oncology Biopharmaceuticals Consumption Value by Type (2025-2030) & (USD Million)
Table 154. South America Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2024) & (USD Million)
Table 155. South America Non-oncology Biopharmaceuticals Consumption Value by Application (2025-2030) & (USD Million)
Table 156. South America Non-oncology Biopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 157. South America Non-oncology Biopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 158. Middle East & Africa Non-oncology Biopharmaceuticals Consumption Value by Type (2019-2024) & (USD Million)
Table 159. Middle East & Africa Non-oncology Biopharmaceuticals Consumption Value by Type (2025-2030) & (USD Million)
Table 160. Middle East & Africa Non-oncology Biopharmaceuticals Consumption Value by Application (2019-2024) & (USD Million)
Table 161. Middle East & Africa Non-oncology Biopharmaceuticals Consumption Value by Application (2025-2030) & (USD Million)
Table 162. Middle East & Africa Non-oncology Biopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 163. Middle East & Africa Non-oncology Biopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 164. Non-oncology Biopharmaceuticals Raw Material
Table 165. Key Suppliers of Non-oncology Biopharmaceuticals Raw Materials
LIST OF FIGURES
Figure 1. Non-oncology Biopharmaceuticals Picture
Figure 2. Global Non-oncology Biopharmaceuticals Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Non-oncology Biopharmaceuticals Consumption Value Market Share by Type in 2023
Figure 4. Biologics
Figure 5. Biosimilars
Figure 6. Global Non-oncology Biopharmaceuticals Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Non-oncology Biopharmaceuticals Consumption Value Market Share by Application in 2023
Figure 8. Immunology Picture
Figure 9. Endocrinology Picture
Figure 10. Others Picture
Figure 11. Global Non-oncology Biopharmaceuticals Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Non-oncology Biopharmaceuticals Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Non-oncology Biopharmaceuticals Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Non-oncology Biopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Non-oncology Biopharmaceuticals Consumption Value Market Share by Region in 2023
Figure 16. North America Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Non-oncology Biopharmaceuticals Revenue Share by Players in 2023
Figure 22. Non-oncology Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Non-oncology Biopharmaceuticals Market Share in 2023
Figure 24. Global Top 6 Players Non-oncology Biopharmaceuticals Market Share in 2023
Figure 25. Global Non-oncology Biopharmaceuticals Consumption Value Share by Type (2019-2024)
Figure 26. Global Non-oncology Biopharmaceuticals Market Share Forecast by Type (2025-2030)
Figure 27. Global Non-oncology Biopharmaceuticals Consumption Value Share by Application (2019-2024)
Figure 28. Global Non-oncology Biopharmaceuticals Market Share Forecast by Application (2025-2030)
Figure 29. North America Non-oncology Biopharmaceuticals Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Non-oncology Biopharmaceuticals Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Non-oncology Biopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Non-oncology Biopharmaceuticals Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Non-oncology Biopharmaceuticals Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Non-oncology Biopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 39. France Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 46. China Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 49. India Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Non-oncology Biopharmaceuticals Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Non-oncology Biopharmaceuticals Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Non-oncology Biopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Non-oncology Biopharmaceuticals Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Non-oncology Biopharmaceuticals Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Non-oncology Biopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 63. Non-oncology Biopharmaceuticals Market Drivers
Figure 64. Non-oncology Biopharmaceuticals Market Restraints
Figure 65. Non-oncology Biopharmaceuticals Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Non-oncology Biopharmaceuticals in 2023
Figure 68. Manufacturing Process Analysis of Non-oncology Biopharmaceuticals
Figure 69. Non-oncology Biopharmaceuticals Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Non-oncology Biopharmaceuticals Picture
Figure 2. Global Non-oncology Biopharmaceuticals Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Non-oncology Biopharmaceuticals Consumption Value Market Share by Type in 2023
Figure 4. Biologics
Figure 5. Biosimilars
Figure 6. Global Non-oncology Biopharmaceuticals Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Non-oncology Biopharmaceuticals Consumption Value Market Share by Application in 2023
Figure 8. Immunology Picture
Figure 9. Endocrinology Picture
Figure 10. Others Picture
Figure 11. Global Non-oncology Biopharmaceuticals Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Non-oncology Biopharmaceuticals Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Non-oncology Biopharmaceuticals Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Non-oncology Biopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Non-oncology Biopharmaceuticals Consumption Value Market Share by Region in 2023
Figure 16. North America Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Non-oncology Biopharmaceuticals Revenue Share by Players in 2023
Figure 22. Non-oncology Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Non-oncology Biopharmaceuticals Market Share in 2023
Figure 24. Global Top 6 Players Non-oncology Biopharmaceuticals Market Share in 2023
Figure 25. Global Non-oncology Biopharmaceuticals Consumption Value Share by Type (2019-2024)
Figure 26. Global Non-oncology Biopharmaceuticals Market Share Forecast by Type (2025-2030)
Figure 27. Global Non-oncology Biopharmaceuticals Consumption Value Share by Application (2019-2024)
Figure 28. Global Non-oncology Biopharmaceuticals Market Share Forecast by Application (2025-2030)
Figure 29. North America Non-oncology Biopharmaceuticals Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Non-oncology Biopharmaceuticals Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Non-oncology Biopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Non-oncology Biopharmaceuticals Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Non-oncology Biopharmaceuticals Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Non-oncology Biopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 39. France Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Non-oncology Biopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 46. China Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 49. India Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Non-oncology Biopharmaceuticals Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Non-oncology Biopharmaceuticals Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Non-oncology Biopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Non-oncology Biopharmaceuticals Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Non-oncology Biopharmaceuticals Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Non-oncology Biopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Non-oncology Biopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 63. Non-oncology Biopharmaceuticals Market Drivers
Figure 64. Non-oncology Biopharmaceuticals Market Restraints
Figure 65. Non-oncology Biopharmaceuticals Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Non-oncology Biopharmaceuticals in 2023
Figure 68. Manufacturing Process Analysis of Non-oncology Biopharmaceuticals
Figure 69. Non-oncology Biopharmaceuticals Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
